Vibramycin(Doxycycline Hyclate)
PFE
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Pfizer Inc.
$400
Medicare cost, 2024
$400
Medicare cost, 2024
Medicare drug plans spent $400 on Vibramycin (doxycycline hyclate) in 2024, for 20 prescriptions and refills filled by 13 patients. Spending fell 48% from 2023 to 2024. It is made by Pfizer Inc. (PFE).
Medicare cost, 2024
$400
-48.2% from 2023
Prescriptions
20
$19.98 per claim
Patients
13
16 prescribers
Total spending, 2024
$400
$30.74 per patient
Questions and answers
How much does Medicare spend on Vibramycin?
Medicare prescription drug plans paid $400 for Vibramycin in 2024, for 20 prescriptions and refills to 13 patients (down 48.2% from 2023). The average cost per claim was $19.98.
Who makes Vibramycin?
Vibramycin is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Vibramycin was $400 in 2024, after a high of $1,479 in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 25 | 32 | 23 | $771 |
| 2024 | 16 | 20 | 13 | $400 |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm | 20 | $400 |
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 68,867 side-effect reports named doxycycline hyclate, the active ingredient of Vibramycin (reports from 2003 on). 50,016 of them (72.6%) were serious, 6,925 named a death and 22,279 named a hospital stay. The reactions named most often were drug ineffective, nausea and off label use. 28,929 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
68,867
6,735 in 2025 (+2.0% from 2024)
Serious
72.6%
50,016 reports
Deaths named
6,925
10.1% of reports
Hospital stays
22,279
32.4% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Vibramycin?
68,867 reports from 2003 through September 2026 named doxycycline hyclate, the active ingredient of Vibramycin. 50,016 of them (72.6%) were serious, 6,925 named a death and 22,279 named a hospital stay.
What are the most reported side effects of Vibramycin?
5,423 reports named drug ineffective, the reaction named most often, followed by nausea (5,110) and off label use (4,924). In the last 5 years the reaction named most often was off label use (3,410 reports). A report can name several reactions.
How many side-effect reports named Vibramycin in 2025?
6,735 reports were received in 2025 (+2.0% from 2024). 2026 so far: 4,677 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Vibramycin caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Vibramycin caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with doxycycline hyclate: Doxycycline Hyclate, Doryx Mpc, Targadox, Doryx, Doxycycline Hyclate*
- Makers on the stock market:
PFE·PFE drug pipeline - Drug approvals (35 approvals on file for doxycycline hyclate) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (doxycycline hyclate) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.